Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN‐TAVI registry

2020 ◽  
Author(s):  
Hiromu Hase ◽  
Nobuhiro Yoshijima ◽  
Ryo Yanagisawa ◽  
Makoto Tanaka ◽  
Hikaru Tsuruta ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Japanese Patients ◽  
Aortic Annulus ◽  
Transcatheter Aortic Valve ◽  
Small Aortic Annulus ◽  
Sapien 3

scholarly journals Valve Hemodynamics and Clinical Outcomes After Transcatheter Aortic Valve Replacement for a Small Aortic Annulus

2019 ◽  
Vol 60 (1) ◽  
pp. 86-92 ◽  
Author(s):  
Norihiko Kamioka ◽  
Takeshi Arita ◽  
Michiya Hanyu ◽  
Masaomi Hayashi ◽  
Shun Watanabe ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Clinical Outcomes ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Aortic Annulus ◽  
Transcatheter Aortic Valve ◽  
Small Aortic Annulus

scholarly journals Comparison of Transcatheter Aortic Valve Replacement between Self-Expanding versus Balloon-Expandable Valves in Patients with Small Aortic Annulus

2021 ◽  
Vol 51 ◽  
Author(s):  
Yong-Joon Lee ◽  
Seung-Jun Lee ◽  
Sung-Jin Hong ◽  
Chi-Young Shim ◽  
Chul-Min Ahn ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Aortic Annulus ◽  
Transcatheter Aortic Valve ◽  
Small Aortic Annulus

Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States

2021 ◽  
Vol 14 (9) ◽  
Author(s):  
Tamim M. Nazif ◽  
Thomas J. Cahill ◽  
David Daniels ◽  
James M. McCabe ◽  
Mark Reisman ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Clinical Outcomes ◽  
Valve Replacement ◽  
Heart Valve ◽  
Transcatheter Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Transcatheter Heart Valve ◽  
Sapien 3 ◽  
Transcatheter Valve

Background: Paravalvular regurgitation (PVR) after transcatheter aortic valve replacement is associated with adverse clinical outcomes. The SAPIEN 3 Ultra (Ultra) is a new generation balloon-expandable transcatheter heart valve with a modified external skirt that is designed to reduce PVR, but reports of clinical and echocardiographic outcomes are limited. The aim of this study was to compare short-term outcomes of patients undergoing transcatheter aortic valve replacement with the Ultra and the original SAPIEN 3 (S3) transcatheter heart valve in a large national registry. Methods: Data from The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry was used to compare patients who underwent elective, transfemoral transcatheter aortic valve replacement with the Ultra or S3 transcatheter heart valve. Clinical and echocardiographic outcomes were analyzed in a propensity-matched cohort at discharge and 30 days. Results: Patients who underwent transcatheter aortic valve replacement with Ultra (N=1324) from January 2019 to February 2020 were propensity score–matched with patients treated with S3 (N=32 982) during the same period, resulting in 1324 matched pairs. There was no difference in the rate of device success between patients treated with Ultra and S3 (97.1% versus 98.0%, P =0.11). At hospital discharge, PVR was significantly reduced with Ultra compared with S3, with mild PVR in 9.0% versus 13.9% and moderate or greater PVR in 0.1% versus 0.4% (overall P <0.01). At 30 days, there were no differences between Ultra and S3 recipients in the rates of all-cause mortality or stroke (1.8% versus 2.8%, P =0.10), major vascular complications (1.1% versus 1.0%, P =0.84), or permanent pacemaker implantation (6.4% versus 6.2%, P =0.81). Conclusions: In this propensity-matched analysis from the Transcatheter Valve Therapy Registry, the Ultra transcatheter heart valve was associated with similar procedural and 30-day clinical outcomes, but reduced incidence of PVR, compared with S3. The clinical benefit of less PVR should be evaluated in longer-term studies.

scholarly journals Comparing the Procedural and Clinical Outcomes of Sapien XT and Sapien 3 Valves in Transcatheter Aortic Valve Replacement in Korean Patients

2020 ◽  
Vol 50 (10) ◽  
pp. 907 ◽  
Author(s):  
Hyungdon Kook ◽  
Duck Hyun Jang ◽  
Kyung-Sook Yang ◽  
Hyung Joon Joo ◽  
Jae Hyoung Park ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Clinical Outcomes ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Korean Patients ◽  
Transcatheter Aortic Valve ◽  
Sapien 3

scholarly journals TCT CONNECT-117 Impact of Pre-Existing Pacemaker on Survival and Echocardiographic Outcomes After Transcatheter Aortic Valve Replacement With SAPIEN-3 Valve

2020 ◽  
Vol 76 (17) ◽  
pp. B51-B52
Author(s):  
Yasser Sammour ◽  
Rama Dilip Gajulapalli ◽  
Hassan Lak ◽  
Sanchit Chawla ◽  
Cameron Incognito ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Sapien 3

scholarly journals Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve

2020 ◽  
Vol 13 (2) ◽  
pp. 210-216 ◽  
Author(s):  
Aditya Sengupta ◽  
Syed Zaid ◽  
Norihiko Kamioka ◽  
Juan Terre ◽  
Masaki Miyasaka ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Edwards Sapien ◽  
Sapien 3
Sign in / Sign up

Export Citation Format

Share Document